Radiosensitizing Effect of Irinotecan and Oxaliplatin alone and in Combination with 5-Fluorouracil on human colorectal Tumor Cells

被引:0
|
作者
Frerker, Bernd [1 ]
Bock, Felix [1 ]
Cappel, Marie-Louise [2 ]
Klautke, Gunther [3 ]
Hildebrandt, Guido [1 ]
Manda, Katrin [1 ]
机构
[1] Univ Med Rostock, Klin & Poliklin Strahlentherapie, Rostock, Germany
[2] CSL Plasma GmbH, Marburg, Germany
[3] Klinikum Chemnitz gGmbH, Klin Radioonkol, Chemnitz, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P03-7-jD
引用
收藏
页码:S72 / S72
页数:1
相关论文
共 50 条
  • [1] Radiosensitizing Effects of Irinotecan versus Oxaliplatin Alone and in Combination with 5-Fluorouracil on Human Colorectal Cancer Cells
    Frerker, Bernd
    Bock, Felix
    Cappel, Marie-Louise
    Kriesen, Stephan
    Klautke, Gunther
    Hildebrandt, Guido
    Manda, Katrin
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [2] Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer
    Fioravanti, Anna
    Canu, Bastianina
    Ali, Greta
    Orlandi, Paola
    Allegrini, Giacomo
    Di Desidero, Teresa
    Emrilenegger, Urban
    Fontanini, Gabriella
    Danesi, Romano
    Del Tacca, Mario
    Falcone, Alfredo
    Bocci, Guido
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 619 (1-3) : 8 - 14
  • [3] Colorectal cancer metastasis resectability after treatment with the the combination of 5-fluorouracil, oxaliplatin and irinotecan
    Manzano, Jose L.
    Yuste, Ana L.
    Alonso, Vicente
    Vega, Maria E.
    Marcuello, Eugenio
    Carrato, Alfredo
    Martinez-Villacampa, Mercedes
    Tabernero, Jose M.
    Sastre, Javier
    Abad, Albert
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 283 - 284
  • [4] Effect of metformin alone and in combination with 5-fluorouracil (5FU), oxaliplatin (O) and irinotecan (I) on human colon cancer cell lines
    Kunthur, A.
    Aldwairi, A.
    Simmen, F.
    Govindarajan, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Combination of irinotecan, oxaliplatin and 5-fluorouracil as a rechallenge regimen for heavily pretreated metastatic colorectal cancer patients
    Fernandes G.D.S.
    Braghiroli M.I.
    Artioli M.
    Paterlini A.C.C.R.
    Teixeira M.C.
    Gumz B.P.
    Girardi D.M.
    Braghiroli O.F.M.
    Costa F.P.
    Hoff P.M.
    [J]. Journal of Gastrointestinal Cancer, 2018, 49 (4) : 470 - 475
  • [6] In vitro and in vivo antitumor effect of HDAC inhibitor in combination with irinotecan, 5-fluorouracil or oxaliplatin in colon cancer
    Na, Young-Soon
    Kim, Tae Won
    Park, Hyo Suk
    Lee, Jae-Lyun
    Ro, Seonggu
    Kim, Jin Cheon
    Lee, Jung Shin
    Jang, Se Jin
    [J]. CANCER RESEARCH, 2009, 69
  • [7] Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer
    McWilliams, Robert R.
    Goetz, Matthew P.
    Morlan, Bruce W.
    Salim, Muhammad
    Rowland, Kendrith M.
    Krook, James E.
    Ames, Matthew M.
    Erlichman, Charles
    [J]. CLINICAL COLORECTAL CANCER, 2007, 6 (07) : 516 - 521
  • [8] Optimal use of the combination of irinotecan and 5-fluorouracil
    Benson, AB
    Goldberg, RM
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (03) : 68 - 77
  • [9] The Effect of 5-Fluorouracil in Combination with Topotecan and Irinotecan on Topoisomerase I Localization in HeLa Cells
    Bischak, M. M.
    Resendes, K. K.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [10] Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer -: A feasibility pilot study
    Calvo, E
    Cortés, J
    González-Cao, M
    Rodríguez, J
    Aramendía, JM
    Fernández-Hidalgo, O
    Martín-Algarra, S
    Salgado, JE
    Martínez-Monge, R
    de Irala, J
    Brugarolas, A
    [J]. ONCOLOGY, 2002, 63 (03) : 254 - 265